The voice of Utah’s life sciences community

Medical Devices

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

BioUtah is the common voice and flag bearer for Utah’s life sciences industry, comprised of medical devices, pharmaceuticals, diagnostics, laboratories, research facilities, and biotechnology of all types. BioUtah connects industry with government, academia, capital markets, media, and service providers. Together we form an ecosystem that fosters collaboration, promotes innovation, and delivers technology that saves lives.

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

2026 Biosphere Magazine Now Available

BioUtah's 2026 Biosphere magazine spotlights the innovators, companies, and milestones shaping Utah's life sciences industry — from early-stage startups to global acquisitions.

BIO Business Solutions

Savings achieved through this program on lab supplies, equipment, shipping and much more, often exceed the annual cost membership in BioUtah.

Bill Tracker

With the Utah legislature in session, follow the bills BioUtah is tracking that affect the life sciences industry.

Featured New Member

CSafe is a global provider of temperature-controlled shipping solutions for the life sciences industry.

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

September 17, 2026

BioUtah Member Appreciation BBQ 2026 Recap

Thanks to all who joined us andt sponsored the event! Be sure to check out our event gallery!

September 17, 2026

Epitel Adds Proven Medtech Leader James Reinstein to Board As Company Enters Next Stage of Growth

Reinstein brings medtech and epilepsy experience as the company expands REMI® and enters its next stage of growth.

September 17, 2026

Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression

Study informed by encouraging exploratory efficacy findings and a favorable safety profile in the prior Phase 3 trial.

September 17, 2026

CLENE ANNOUNCES $4 MILLION REGISTERED DIRECT OFFERING

Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s CEO and other existing shareholders.

September 17, 2026

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Blood-based testing could open new markets for the Co-Dx® PCR platform, including HIV and hepatitis B and C.

September 17, 2026

Myriad Genetics Appoints Vishal Sikri Executive Vice President – Commercial

Vishal Sikri has been promoted to Executive Vice President – Commercial, effective September 16, 2026.

September 17, 2026

PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers

PDUFA Target Action Date Set for March 16, 2027.

September 17, 2026

Utah Medical Products Acquires Orion Medical Supplies for $3.6 Million

Utah Medical Products acquires UK-based Orion Medical Supplies for $3.6 million to expand its Harm Reduction medical device distribution in Europe.